Candriam SCA’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
NAMA
Candriam SCA's VCYT Position: Q4 2024 in Review
Candriam SCA sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 231,676 shares — an estimated $7.89M sold.
Candriam SCA first reported a position in VCYT in Q1 2019 and held it in 17 quarters. The position peaked at $16.8M in Q4 2023. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.
- Candriam SCA reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
- Candriam SCA sold 231,676 Veracyte shares in Q4 2024, an estimated $7.89M.
- Candriam SCA first reported a position in Veracyte in Q1 2019 and held it in 17 quarters.
- Candriam SCA's Veracyte position peaked at $16.8M in Q4 2023.
- 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.
Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.